CY1107736T1 - Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις - Google Patents

Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις

Info

Publication number
CY1107736T1
CY1107736T1 CY20071101187T CY071101187T CY1107736T1 CY 1107736 T1 CY1107736 T1 CY 1107736T1 CY 20071101187 T CY20071101187 T CY 20071101187T CY 071101187 T CY071101187 T CY 071101187T CY 1107736 T1 CY1107736 T1 CY 1107736T1
Authority
CY
Cyprus
Prior art keywords
unsubstituted
substituted
benzoxathiazole
derived
compounds
Prior art date
Application number
CY20071101187T
Other languages
English (en)
Inventor
Stefan Petry
Karl-Heinz Baringhaus
Swen HÖLDER
Guenter Mueller
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of CY1107736T1 publication Critical patent/CY1107736T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D291/00—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms
    • C07D291/08—Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Adhesives Or Adhesive Processes (AREA)

Abstract

Η προκειμένη εφεύρεση αφορά σε υποκατεστημένα και μη υποκατεστημένα 2,2-διοξείδια 3Η-βενζο[1,2,3]οξαθειαζολίων, 2,2-διοξείδια 1,3-διυδρο-βενζο[1,2,5]-θειαδιαζολίων και 2,2-διοξείδια 1,3-διυδρο-βενζο[c]ισοθειαζολίων, στην παρασκευή τους και την χρησιμοποίηση τους σε φάρμακα.
CY20071101187T 2000-08-09 2007-09-14 Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις CY1107736T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10038709A DE10038709A1 (de) 2000-08-09 2000-08-09 Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
EP01969532A EP1311264B1 (de) 2000-08-09 2001-07-27 Substituierte und unsubstituierte benzooxathiazole sowie daraus abgeleitete verbindungen

Publications (1)

Publication Number Publication Date
CY1107736T1 true CY1107736T1 (el) 2013-04-18

Family

ID=7651742

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101187T CY1107736T1 (el) 2000-08-09 2007-09-14 Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις

Country Status (13)

Country Link
US (3) US6566390B2 (el)
EP (1) EP1311264B1 (el)
JP (1) JP2004505916A (el)
AT (1) ATE365552T1 (el)
AU (1) AU2001289763A1 (el)
CA (1) CA2418084C (el)
CY (1) CY1107736T1 (el)
DE (2) DE10038709A1 (el)
DK (1) DK1311264T3 (el)
ES (1) ES2284689T3 (el)
MX (1) MXPA03000678A (el)
PT (1) PT1311264E (el)
WO (1) WO2002011722A1 (el)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen
GB0227813D0 (en) * 2002-11-29 2003-01-08 Astrazeneca Ab Chemical compounds
DE10308355A1 (de) 2003-02-27 2004-12-23 Aventis Pharma Deutschland Gmbh Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
DE10334309A1 (de) * 2003-07-28 2005-03-03 Aventis Pharma Deutschland Gmbh Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
US7094794B2 (en) 2003-07-28 2006-08-22 Sanofi-Aventis Deutschland Gmbh Substituted thiazole-benzoisothiazole dioxide derivatives, process for their preparation and their use
US7141596B2 (en) 2003-10-08 2006-11-28 Incyte Corporation Inhibitors of proteins that bind phosphorylated molecules
DE102004026532A1 (de) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CA2615774C (en) * 2005-07-21 2014-12-09 Rensselaer Polytechnic Institute Large substituent, non-phenolic opioids
WO2008107699A1 (en) * 2007-03-08 2008-09-12 Cambridge Enterprise Limited Diagnosing psychotic disorders
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2766349B1 (de) * 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
US8828995B2 (en) 2011-03-08 2014-09-09 Sanofi Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120057A1 (de) * 2011-03-08 2012-09-13 Sanofi Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2013078413A1 (en) * 2011-11-22 2013-05-30 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Modulators of lipid storage

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
DE3311636A1 (de) * 1983-03-30 1984-10-04 Bayer Ag, 5090 Leverkusen Neue fuenfgliedrige stickstoffhaltige heterocyclen, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
US5504095A (en) * 1990-09-19 1996-04-02 Pfizer Inc. Aminobenzosultam derivatives as lipoxygenase inhibitors
US5130432A (en) * 1990-12-21 1992-07-14 Syntex (U.S.A.) Inc. Process for preparing cyclic amines and intermediate products thereof
EP0549348A1 (en) * 1991-12-24 1993-06-30 PHARMACIA S.p.A. Arylidene-heterocyclic derivatives, process for their preparation and their use as tyrisine kinase inhibitors
DE69525763T2 (de) * 1994-04-11 2002-10-02 Chugai Seiyaku K.K., Tokio/Tokyo 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN
JPH07325942A (ja) 1994-05-31 1995-12-12 Mitsubishi Heavy Ind Ltd カード類処理装置
CA2188772A1 (en) * 1994-06-08 1995-12-14 Balreddy Kamireddy Cyclic sulfonamide herbicides
WO1997003974A2 (de) 1995-07-20 1997-02-06 Basf Aktiengesellschaft Chromanderivate, deren herstellung und deren verwendung als stabilisatoren von organischen material gegenüber licht, sauerstoff un wärme
US5874382A (en) * 1996-11-13 1999-02-23 E. I. Du Pont De Nemours And Company Cyclic sulfonamide herbicides
AR008331A1 (es) * 1997-01-23 1999-12-29 Smithkline Beecham Corp Compuestos antagonistas de un receptor de il-8, uso de los mismos para la fabricacion de medicamentos, procedimiento para su obtencion, composicionesfarmaceuticas que los contienen
US5929250A (en) * 1997-01-23 1999-07-27 Smithkline Beecham Corporation IL-8 receptor antagonists
TR199901710T2 (xx) * 1997-01-23 1999-09-21 Smithkline Beecham Corporation IL-8 resept�r antagonistleri.
DE19738005A1 (de) * 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
AR015426A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol antagonistas del receptor de il-8, composicion farmaceutica que los contiene, su uso para la manufactura de un medicamento,procedimiento para su preparacion, compuestos intermediarios y procedimiento para su preparacion
AR015425A1 (es) * 1997-09-05 2001-05-02 Smithkline Beecham Corp Compuestos de benzotiazol, composicion farmaceutica que los contiene, su uso en la manufactura de un medicamento, procedimiento para su preparacion,compuestos intermediarios y procedimiento para su preparacion
CA2318195A1 (en) * 1998-01-16 1999-07-22 Deborah Lynne Bryan Il-8 receptor antagonists
HUP0102612A2 (hu) * 1998-03-12 2001-11-28 Novo Nordisk A/S Fehérje-tirozinfoszfatázokat moduláló vegyületek és ezeket tartalmazó gyógyászati készítmények
US6001867A (en) * 1998-05-12 1999-12-14 American Home Products Corporation 1-aryl-dibenzothiophenes
WO2000005216A1 (en) * 1998-07-23 2000-02-03 Smithkline Beecham Corporation Il-8 receptor antagonists
WO2000006557A1 (en) * 1998-07-27 2000-02-10 Smithkline Beecham Corporation Novel process for making il-8 receptor antagonists
JP2002527446A (ja) * 1998-10-14 2002-08-27 バーゼル、ポリプロピレン、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツング 固定した架橋を有するメタロセン
US6339098B1 (en) * 1999-05-04 2002-01-15 American Home Products Corporation 2,1-benzisothiazoline 2,2-dioxides
US6319912B1 (en) * 1999-05-04 2001-11-20 American Home Products Corporation Cyclic regimens using 2,1-benzisothiazoline 2,2-dioxides
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
CA2418084A1 (en) 2003-02-04
PT1311264E (pt) 2007-07-31
DK1311264T3 (da) 2007-09-10
WO2002011722A1 (de) 2002-02-14
US20020055523A1 (en) 2002-05-09
US6566390B2 (en) 2003-05-20
DE50112671D1 (de) 2007-08-09
US20030191161A1 (en) 2003-10-09
ES2284689T3 (es) 2007-11-16
CA2418084C (en) 2010-03-30
AU2001289763A1 (en) 2002-02-18
DE10038709A1 (de) 2002-02-28
MXPA03000678A (es) 2003-06-06
JP2004505916A (ja) 2004-02-26
US7211592B2 (en) 2007-05-01
EP1311264B1 (de) 2007-06-27
ATE365552T1 (de) 2007-07-15
EP1311264A1 (de) 2003-05-21
US20050043373A1 (en) 2005-02-24

Similar Documents

Publication Publication Date Title
CY1107736T1 (el) Υποκατεστημενα και μη υποκατεστημενα βενζοξαθειαζολια, ως και εκπορευομενες απο αυτα ενωσεις
MA27040A1 (fr) Nucleosides substitues en 4'
DE60003863D1 (de) Dioxocyclopentylhydroxamsäure
DE50214263D1 (de) Emollients und kosmetische zusammensetzungen enthaltend 2-methyl-1,3-propandioldiester
ATE414079T1 (de) 2,4-disubstituierte thiazolyl derivate
PT1274687E (pt) Derivados de 1,2,3,4-tetra-hidroisoquinolina
PA8481301A1 (es) Derivados de 4,4-biarilpiperidina
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
BRPI0412851A (pt) benzamidazóis de n-metila-substituìdos
HUP0203520A2 (hu) Bisz-acil-amidokat tartalmazó szilárd kozmetikai vagy gyógyszerészeti készítmény
MXPA05004247A (es) Cromonas y derivados de cromona y usos de los mismos.
AU2002258971A1 (en) Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-benzodioxan
MXPA01011872A (es) Derivados de furanona como inhibidores de la catepsina s.
IT1320080B1 (it) Composizione per uso farmaceutico o dietetico.
EP1900802A3 (en) Toilet bar having a latent acidifier
DE69913697D1 (de) Naphtho- und dihydrobenzothiophenderivate als cytotoxische antitumormittel
DK0888327T3 (da) Benzopyranderivater, som har antagonistisk virkning imod leukotriener
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
NO20055002D0 (no) Benzol[1,2,5]tiadiazolforbindelser
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
DE60005462D1 (de) Tintenzusammensetzungen enthaltend 1,3,5-Trioxan
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
TR200103430T2 (tr) Aminoalkil ile ikame edilmiş (benzodioksan, benzofuran veya benzopiran) türevleri
ITMI982857A0 (it) Processo per la sintesi di 5-(a-idrossialchil)benzo[1,3]diossoli
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica